Development of nanobody-based radiopharmaceuticals for cancer treatment.

Project Details

Description

In this project we will use nanobodies that focus specifically on membrane-bound tumor antigens and develop a universal method for labeling these nanobodies with Lu-177. The labeled nanobodies will be evaluated in terms of immunoreactivity, biodistribution, tumor penetration and, finally, therapeutic potential.
AcronymFWOAL564
StatusFinished
Effective start/end date1/01/1031/12/13

Keywords

  • image processing techniques
  • SPECT
  • image modelling and medical science
  • PET
  • small animal imaging
  • radiopharmaceuticals

Flemish discipline codes in use since 2023

  • (Bio)medical engineering
  • Electrical and electronic engineering
  • Physical sciences
  • Basic sciences

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.